Lush CW - Search Results

1

Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.

Aronne L, Fujioka K, Aroda V, Chen K, Halseth A, Kesty NC, Burns C, Lush CW, Weyer C. Aronne L, et al. Among authors: lush cw. J Clin Endocrinol Metab. 2007 Aug;92(8):2977-83. doi: 10.1210/jc.2006-2003. Epub 2007 May 15. J Clin Endocrinol Metab. 2007. PMID: 17504894 Clinical Trial.

2

Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.

Smith SR, Blundell JE, Burns C, Ellero C, Schroeder BE, Kesty NC, Chen KS, Halseth AE, Lush CW, Weyer C. Smith SR, et al. Among authors: lush cw. Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E620-7. doi: 10.1152/ajpendo.00217.2007. Epub 2007 May 15. Am J Physiol Endocrinol Metab. 2007. PMID: 17505051 Free article. Clinical Trial.

3

Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects.

Chapman I, Parker B, Doran S, Feinle-Bisset C, Wishart J, Lush CW, Chen K, Lacerte C, Burns C, McKay R, Weyer C, Horowitz M. Chapman I, et al. Among authors: lush cw. Obesity (Silver Spring). 2007 May;15(5):1179-86. doi: 10.1038/oby.2007.626. Obesity (Silver Spring). 2007. PMID: 17495194 Free article. Clinical Trial.

4

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes.

Chapman I, Parker B, Doran S, Feinle-Bisset C, Wishart J, Strobel S, Wang Y, Burns C, Lush C, Weyer C, Horowitz M. Chapman I, et al. Diabetologia. 2005 May;48(5):838-48. doi: 10.1007/s00125-005-1732-4. Epub 2005 Apr 21. Diabetologia. 2005. PMID: 15843914 Clinical Trial.

5

Pramlintide reduced markers of oxidative stress in the postprandial period in patients with type 2 diabetes.

Ceriello A, Lush CW, Darsow T, Piconi L, Corgnali M, Nanayakkara N, Frias JP, Maggs D. Ceriello A, et al. Among authors: lush cw. Diabetes Metab Res Rev. 2008 Feb;24(2):103-8. doi: 10.1002/dmrr.765. Diabetes Metab Res Rev. 2008. PMID: 17694505 Clinical Trial.

6

Effect of pramlintide as an adjunct to basal insulin on markers of cardiovascular risk in patients with type 2 diabetes.

Wysham C, Lush C, Zhang B, Maier H, Wilhelm K. Wysham C, et al. Curr Med Res Opin. 2008 Jan;24(1):79-85. doi: 10.1185/030079908x253537. Curr Med Res Opin. 2008. PMID: 18031595 Clinical Trial.

7

Heme oxygenase modulates hepatic leukocyte sequestration via changes in sinusoidal tone in systemic inflammation in mice.

Wunder C, Scott JR, Lush CW, Brock RW, Bihari A, Harris K, Eichelbrönner O, Potter RF. Wunder C, et al. Among authors: lush cw. Microvasc Res. 2004 Jul;68(1):20-9. doi: 10.1016/j.mvr.2004.03.003. Microvasc Res. 2004. PMID: 15219417

8

Regulation of intestinal nuclear factor-kappaB activity and E-selectin expression during sepsis: a role for peroxynitrite.

Lush CW, Cepinskas G, Kvietys PR. Lush CW, et al. Gastroenterology. 2003 Jan;124(1):118-28. doi: 10.1053/gast.2003.50001. Gastroenterology. 2003. PMID: 12512036

9

Endothelial E- and P-selectin expression in iNOS- deficient mice exposed to polymicrobial sepsis.

Lush CW, Cepinskas G, Sibbald WJ, Kvietys PR. Lush CW, et al. Am J Physiol Gastrointest Liver Physiol. 2001 Feb;280(2):G291-7. doi: 10.1152/ajpgi.2001.280.2.G291. Am J Physiol Gastrointest Liver Physiol. 2001. PMID: 11208553 Free article.

10

Microvascular dysfunction in sepsis.

Lush CW, Kvietys PR. Lush CW, et al. Microcirculation. 2000 Apr;7(2):83-101. doi: 10.1038/sj.mn.7300096. Microcirculation. 2000. PMID: 10802851 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page